Bharat Parenterals Ltd (BSE: 541096) is a Vadodara, Gujarat-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹1,243 Cr, it ranks #1,472 by market cap among the 6,137 Indian listed companies on FinBizNet, and #46 of 86 in Medicinal Chemicals and Botanical Products. At ₹1,729.00 (as of 25 Oct 2026), the share price is 24.1% below its 52-week high of ₹2,277.60 and 44.0% above its 52-week low of ₹1,201.10. The share price is up 7.6% over one year and up 15.7% over three months.
| Current Price | ₹1,729.00 |
|---|---|
| Market Cap | ₹1,243 Cr |
| BSE Code | 541096 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products |
| P/E Ratio | -145.5 |
| Return on Equity | 4.06% |
| Return on Assets | -1.82% |
| 52-Week Range | ₹1,201.10 – ₹2,277.60 |
| 1-Year Price Change | +7.6% |
| 3-Month Price Change | +15.7% |
| Beta (1Y) | 0.64 |
| Dividend Yield | 0.06% |
| Headquarters | Vadodara, Gujarat |
| Website | bplindia.in |
| Revenue | ₹56 Cr |
|---|---|
| Net Profit | ₹4 Cr |
| Net Margin | 6.6% |
| EPS (Basic) | ₹5.31 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Bharat Parenterals Limited engages in the research, development, manufacturing, marketing, sourcing, and distribution of pharmaceutical products in India and internationally. The company provides antibiotics, cardiovascular and central nervous system, antifungal, antimalarial, gastrointestinal tract/alimentary systems, analgesics, anaesthetics, quinolones, erectile dysfunction medicines, nutritional supplements, steroids and hormones, and other drugs. It also engages in manufacturing of general products in capsules, tablets, ointment and creams, injections, oral liquids, and powder sachets forms; and beta lactum and cephalosporin products in capsules, tablets, dry syrup, and powder for injection forms. In addition, it offers eye drops. Bharat Parenterals Limited was incorporated in 1992 and is based in Vadodara, India.
1. Manufacturing of Pharmaceuticals Formulations-This segment manufactures and sells pharmaceutical formulations. It offers products in the areas of anti retroviral, cephalosporins antibiotics, antiprotozoal/anthelmintic, respiratory, antiallergic/anti histaminic/anticold, cleansing agents/skin infections, antibiotic, cardiovascular systems, anti diabetic, anti tuberculosis, anti-fungal, antimalarial, gastroinestinaltract/alimentary systems, antiinflammatory/anti pyretic/analgesics, supplements, central nervous system, anaesthetics, anti viral, steroids and hormones, uterine stimulant, anticancer, and other.
1. Manufacturing Of Pharma Products-61.1% 2. Trading Of Pharma Products-18% 3. Contract Development And Manufacturing Operations-20.9%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4,21,995 Cr | 36.4 | 14.72% | ₹15,300 Cr | +5.4% |
| Zydus Lifesciences Ltd | ₹1,12,020 Cr | 22.2 | 18.32% | ₹8,017 Cr | +14.7% |
| Laurus Labs Ltd | ₹1,11,310 Cr | 125.3 | 17.74% | ₹2,026 Cr | +125.7% |
| Cipla Limited | ₹1,07,048 Cr | 27.6 | 11.74% | ₹7,119 Cr | -14.7% |
| Dr.Reddys Lab | ₹1,02,611 Cr | 24.1 | 11.52% | ₹8,698 Cr | -0.9% |
| Aurobindo Pharma Ltd. | ₹95,910 Cr | 26.8 | 9.93% | ₹9,150 Cr | +41.7% |
| Mankind Pharma | ₹93,977 Cr | 48.7 | 12.45% | ₹4,031 Cr | -9.9% |
| Lupin Ltd | ₹89,426 Cr | 16.6 | 26.91% | ₹8,277 Cr | -1.1% |
| Bharat Parenterals Ltd | ₹1,243 Cr | -145.5 | 4.06% | ₹56 Cr | +7.6% |
Listed by market capitalisation. Ratios are shown for context only.
Bharat Parenterals Ltd is trading at ₹1,729.00, with a market capitalisation of ₹1,243 Cr.
Bharat Parenterals Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).
Bharat Parenterals Ltd has a P/E of -145.5 and a return on equity of 4.06%.
Bharat Parenterals Ltd is listed on the BSE under the scrip code 541096.
Bharat Parenterals Ltd's share price is up 7.6% over one year and up 15.7% over three months. Its 52-week range is ₹1,201.10 to ₹2,277.60.
In Q1 FY27, Bharat Parenterals Ltd reported revenue of ₹56 Cr and net profit of ₹4 Cr, with basic EPS of ₹5.31 (standalone, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.